Association of Frailty and Its Trajectories With the Risk of Cardiovascular–Kidney–Metabolic Syndrome Progression: A Longitudinal Cohort Study
Assoziation von Frailty und ihren Trajektorien mit dem Risiko der Progression des kardiovaskulär-nieren-metabolischen Syndroms: eine longitudinale Kohortenstudie
Geriatrics & Gerontology International · 2026-07 · 26 (7)
DOI: 10.1111/ggi.70627 ↗Auf einen Blick
Bei 5.624 Teilnehmenden war ein höherer Frailty-Index mit einem höheren CVD-Risiko assoziiert. Auch kumulative Frailty und Frailty-Trajektorien sagten das Risiko voraus.
Fragestellung
Wie sind Frailty, ihre Verläufe und das Risiko für die Progression des kardiovaskulär-nieren-metabolischen Syndroms und CVD-Risiko assoziiert?
Methode
Longitudinale Kohortenstudie mit 5.624 Teilnehmenden aus CHARLS; Analyse mit Cox-Modellen, restricted cubic splines und Group-based trajectory modeling; Follow-up 2011 bis 2018.
Ergebnisse
Ein Anstieg des Frailty-Index um 0,1 war nach vollständiger Adjustierung mit 33 % höherem CVD-Risiko verbunden (HR 1,33; 95 %-KI 1,26–1,40). Moderate und hohe zunehmende Trajektorien waren ebenfalls mit höherem Risiko assoziiert (HR 4,63 bzw. 9,33).
Schlussfolgerung der Autor:innen
Frailty ist mit dem Risiko der CKM-Syndrom-Progression assoziiert. CumFI und Frailty-Trajektorien liefern zusätzlich prognostische Informationen für das kardiovaskuläre Risiko.
Kernaussagen
- 0,1 höherer Frailty-Index: HR 1,33 (95 %-KI 1,26–1,40)
- Moderate und hohe Frailty-Trajektorien: höheres CVD-Risiko
- CumFI und Trajektorien ergänzen die Basismessung
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Kohortenstudie in der Zeitschrift Geriatrics & Gerontology International, online erschienen am 02.07.2026. Verfasst von Haoyu Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Shenzhen Traditional Chinese Medicine Hospital, the Fourth Clinical Medical College of Guangzhou University of Chinese Medi…. Hauptthemen laut MEDLINE: Frailty, Metabolic Syndrome, Cardiovascular Diseases, Cardio-Renal Syndrome. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shenzhen Society of Traditional Chinese Medicine, Shenzhen Clinical Research Center for Traditional Chinese Medicine, Guangdong Yiyang Healthcare Charity Foundation.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Aims
Frailty reflects a decline in physiological reserve and has been widely recognized as an important risk factor for cardiovascular disease (CVD). However, the relationships between frailty and the progression of the cardiovascular–kidney–metabolic (CKM) syndrome, as well as between dynamic frailty trajectories and CVD risk, have not been systematically investigated.
Methods
A total of 5624 participants from the China Health and Retirement Longitudinal Study (CHARLS) were included. The association between baseline frailty and CVD risk was analyzed using the Cox proportional hazards model and the restricted cubic spline analyses. We used Group‐based trajectory modeling (GBTM) to identify trajectories of frailty development during the follow‐up periods from 2011 to 2018.
Results
Higher baseline frailty index (FI) was significantly associated with CVD risk in individuals with CKM syndrome stages 0–3; each 0.1 increase in FI was associated with a 33% higher risk of CVD after full adjustment (HR 1.33, 95% CI 1.26–1.40). Cumulative frailty burden, assessed using the cumulative FI (cumFI), showed a strong graded association with CVD risk. Three distinct frailty trajectories were identified. Compared with the low‐level increasing trajectory, moderate‐level and high‐level increasing trajectories were associated with higher CVD risk (HR = 4.63, 95% CI: 3.50–6.14, HR = 9.33, 95% CI: 6.89–12.64). These associations were consistent across multiple sensitivity analyses.
Conclusions
Frailty is associated with the risk of CKM syndrome progression. Beyond baseline assessment, cumFI and frailty trajectories provide prognostic information for cardiovascular risk. Dynamic assessment and early intervention targeting frailty may offer a strategy for preventing CVD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrology, Shenzhen Traditional Chinese Medicine Hospital, the Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, China.
- Medical College of Acu-Moxi and Rehabilitation, Guangzhou University of Chinese Medicine, Guangzhou, China.
ORCID-Profile: Haoyu Yang, Riming He, Shudong Yang
Förderung
- Shenzhen Society of Traditional Chinese Medicine
- Shenzhen Clinical Research Center for Traditional Chinese Medicine
- Guangdong Yiyang Healthcare Charity Foundation
- Shenzhen Science and Technology Program
- Opening Project of State Key Laboratory of Dampness Syndrome of Chinese Medicine
- Sanming Project of Medicine in Shenzhen
- Sanming Project of Medicine in Shenzen Municipality
Zitieren
APA
Yang, H., Wang, Z., Yi, W., Men, L., He, R., & Yang, S. (2026). Association of Frailty and Its Trajectories With the Risk of Cardiovascular–Kidney–Metabolic Syndrome Progression: A Longitudinal Cohort Study. Geriatrics & Gerontology International, 26(7). https://doi.org/10.1111/ggi.70627
Vancouver
Yang H, Wang Z, Yi W, Men L, He R, Yang S. Association of Frailty and Its Trajectories With the Risk of Cardiovascular–Kidney–Metabolic Syndrome Progression: A Longitudinal Cohort Study. Geriatrics & Gerontology International. 2026;26(7). doi:10.1111/ggi.70627
BibTeX
@article{Yang2026,
author = {Yang, Haoyu and Wang, Zhongli and Yi, Wuyong and Men, Ling and He, Riming and Yang, Shudong},
title = {Association of Frailty and Its Trajectories With the Risk of Cardiovascular–Kidney–Metabolic Syndrome Progression: A Longitudinal Cohort Study},
journal = {Geriatrics & Gerontology International},
year = {2026},
volume = {26},
number = {7},
doi = {10.1111/ggi.70627}
}
EUVIMED